Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Facebook
Tweet
Print
Trevyn Flanders, PharmD
PGY2 Oncology Pharmacy Resident
University of Tennessee Medical Center
Poster(s):
(13-087) Assessing appropriate use of pertuzumab and trastuzumab-containing product reloading doses after treatment delays and their effect on outcomes in metastatic HER2-positive breast cancer
Wednesday, December 10, 2025
3:15 PM - 4:15 PM
